NTNX Form 144 Filed for 11,391-Share Sale on NASDAQ
Rhea-AI Filing Summary
Nutanix, Inc. (NTNX) filed a Form 144 reporting a proposed sale of 11,391 common shares valued at $892,413.09 to be sold through Morgan Stanley Smith Barney on NASDAQ on 09/16/2025. The filing notes total shares outstanding of 268,077,453, showing the proposed sale is a small fraction of the company’s outstanding common stock. The shares were acquired on 09/15/2025 as 2,100 restricted stock and 9,291 performance shares, with payment not applicable. The filer affirms they have no undisclosed material adverse information and no other securities were sold in the past three months.
Positive
- None.
Negative
- None.
Insights
TL;DR: Insider plans to sell 11,391 shares (~$0.89M) — de minimis relative to total float; likely not material to valuation.
The Form 144 documents an imminent sale executed via Morgan Stanley Smith Barney for 11,391 common shares with an aggregate market value of $892,413.09 against 268,077,453 shares outstanding. The holdings were acquired one day prior as restricted and performance awards. From a market-impact perspective, the sale represents roughly 0.0042% of outstanding shares, indicating negligible dilution or immediate liquidity pressure on the stock. Disclosure appears routine and compliant with Rule 144 reporting requirements.
TL;DR: Filing is a standard insider disclosure with required attestation; timing and source of shares are clearly stated.
The notice specifies the nature of acquisition (restricted stock and performance shares) and includes the filer’s attestation regarding undisclosed material information, which satisfies the procedural elements of Rule 144 filings. No prior sales in the past three months are reported. Governance implications are limited given the small size of the proposed sale relative to total shares outstanding; the filing enhances transparency about executive compensation-related sales.